January 4, 2016 by Brian Bossetta and Chain Drug Review
mobile payments, Neil Ashe, Walmart, Walmart Global eCommerce, Walmart Pay
2016, Issue 01-04-2016, Issues, News
BENTONVILLE, Ark. — Walmart knows customers want to save not just money but also time. To meet that customer need, the retailer has introduced Walmart Pay — “a fast, easy and secure way for customers to pay with their smartphones in Walmart stores.” Built with the goal of improving how customers check out and dramatically
January 4, 2016 by Scot Meyer and Chain Drug Review
Medicare, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services, Enhanced MTM Demonstration, Medicare Part D enhanced MTM model, medication therapy management, MTM, NACDS, National Association of Chain Drug Stores, Steve Anderson
2016, Issue 01-04-2016, Issues, News
WASHINGTON — A bipartisan group of congressional representatives is urging that retail pharmacists play a part in a new initiative designed to improve the use of medication therapy management in Medicare. Forty-four members of the House of Representatives — 24 Republicans and 20 Democrats — signed a letter to Secretary of Health and Human Services
January 4, 2016 by John Schultz and Chain Drug Review
Diplomat Pharmacy, Gary Kadlec, specialty pharmacy, URAC
2016, Issue 01-04-2016, Issues, News
FLINT, Mich. — Diplomat Pharmacy Inc. has been awarded full Specialty Pharmacy reaccreditation by URAC, a Washington, D.C.-based health care accrediting organization that establishes quality standards for the health care industry. Diplomat has been fully accredited for specialty pharmacy since 2012. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care
January 4, 2016 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, chain drug store business, community pharmacy, CVS Health, Jeffrey Woldt, Omnicare, Rite Aid, Target Corp., Valeant Pharmaceuticals, Walgreens Boots Alliance
2016, Issue 01-04-2016, Issues, Opinion
In many significant ways, the chain drug store business looks very different at the start of 2016 than it did a year ago. Walgreens Boots Alliance, which emerged from a two-step merger process at the close of 2014, spent the past 12 months rationalizing operations in the United States and developing synergies with its retail
January 4, 2016 by David Pinto and Chain Drug Review
chain drug retailing, David Pinto, George Riedl, Helena Foulkes, John Standley, mass retailing, Stefano Pessina
2016, Issue 01-04-2016, Issues, Opinion
Christmas is over, yesterday’s news. And the mass retailing community is scampering to assess its impact on sales, earnings and the future. For chain drug retailers, this holiday selling season, like so many before it, was acceptable, if hardly record-setting. As in previous years, America’s drug chains suffered from an absence of exciting new products